Diabetes Kongress 2019
zur Liste
Prof. Dr. Christoph Wanner
Würzburg University Clinic Germany
  • Vortrag Composite retinopathy outcome in patients treated with empagliflozin versus placebo in the EMPA-REG OUTCOME trial Speaker
    Datum: 30.05.2019 , Zeit: 14:56 | Thema: 06. Diabeteskomplikationen / Begleiterkrankungen
    Details
  • Vortrag Empagliflozin Improves Kidney Outcomes Irrespective of Control of Blood Pressure, Low-Density Lipoprotein Cholesterol and HbA1c Speaker
    Datum: 31.05.2019 , Zeit: 11:29 | Thema: 06. Diabeteskomplikationen / Begleiterkrankungen
    Details